K.J. Harrison & Partners Inc Bristol Myers Squibb CO Transaction History

K.J. Harrison & Partners Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $719,714 - $839,018	-13,420 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $92,384 - $104,688	1,600 Added 13.54%	13,420 $832,000
Q2 2020 Aug 03, 2020	SELL	$54.82 - $64.09 $27,410 - $32,045	-500 Reduced 4.06%	11,820 $695,000
Q1 2020 May 05, 2020	BUY	$46.4 - $67.43 $107,648 - $156,437	2,320 Added 23.2%	12,320 $687,000
Q3 2019 Oct 25, 2019	SELL	$42.77 - $50.71 $128,310 - $152,130	-3,000 Reduced 23.08%	10,000 $507,000
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $490,820 - $542,740	-11,000 Reduced 45.83%	13,000 $590,000
Q1 2019 Apr 26, 2019	BUY	$45.12 - $53.8 $1.08 Million - $1.29 Million	24,000 New	24,000 $1.15 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

Stay updated on K.J. Harrison & Partners Inc with notifications on news.